Information Letter on Lynparza® 50 mg hard capsules (active ingredient olaparib): discontinuation of production at the end of 2021
2021.06.29
Active substance: olaparib
AstraZeneca informs that the production of Lynparza® 50 mg hard capsules (active ingredient: olaparib) will be discontinued at the end of 2021.
Download DHPC/Information letter , Download_VeroeffentlichtAm_EN